Enspryng

satralizumab · Genentech (Roche)

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Enspryng, covering 2020-08-14 to 2026-08-21. Get the full timeline:

Most recent: EMA Authorised: Enspryng (satralizumab) — Roche Registration GmbH